Jushi Holdings Inc. (JUSHF)
OTCMKTS
· Delayed Price · Currency is USD
0.3200
+0.0200 (6.67%)
Apr 17, 2025, 3:58 PM EDT
Jushi Holdings Revenue
In the year 2024, Jushi Holdings had annual revenue of $257.53M, down -4.42%. Jushi Holdings had revenue of $65.86M in the quarter ending December 31, 2024, a decrease of -2.82%.
Revenue
257.53M
Revenue Growth
-4.42%
P/S Ratio
0.24
Revenue / Employee
208.69K
Employees
1,234
Market Cap
62.94M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 210.49M |
American Oncology Network | 1.76B |
Jushi Holdings News
- 22 hours ago - Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Mansfield in Ohio, Expanding Its Statewide Retail Footprint - GlobeNewsWire
- 4 weeks ago - Jushi Holdings Inc. Announces Ohio Retail Updates Including the Opening of Beyond Hello™ Warren, Expanding Its Presence in Ohio's Emerging Adult-Use Market - GlobeNewsWire
- 6 weeks ago - Jushi Holdings Inc. (JUSHF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Jushi Holdings Inc Q4 2024 Earnings: Revenue Surpasses Estimates at $65.9M, EPS Misses at -$0.06 - GuruFocus
- 6 weeks ago - Jushi Holdings GAAP EPS of -$0.06 in-line, revenue of $65.9M beats by $2.4M - Seeking Alpha
- 6 weeks ago - Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Jushi Holdings Inc (XCNQ:JUSH) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus
- 7 weeks ago - Jushi Holdings Inc. Announces Opening of Relocated Dispensary in Linwood, Pennsylvania through its Subsidiary, Franklin Bioscience – SE LLC - GlobeNewsWire